FibroGen, Inc.
FGEN
$0.2912
-$0.0269-8.46%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 17.98M | -17.08M | -15.54M | -32.93M | -56.23M |
Total Depreciation and Amortization | 352.00K | 739.00K | 781.00K | 820.00K | 1.88M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -1.02M | 13.06M | 5.43M | 6.88M | 9.38M |
Change in Net Operating Assets | -47.78M | -5.09M | -30.53M | -34.05M | 26.66M |
Cash from Operations | -30.47M | -8.38M | -39.87M | -59.29M | -18.32M |
Capital Expenditure | -141.00K | -82.00K | -14.00K | -29.00K | -251.00K |
Sale of Property, Plant, and Equipment | 206.00K | 837.00K | 3.00K | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | 0.00 |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 1.66M | 0.00 | 72.25M | 51.31M | 10.49M |
Cash from Investing | 1.72M | 755.00K | 72.24M | 51.28M | 10.24M |
Total Debt Issued | -- | -- | -- | -- | 0.00 |
Total Debt Repaid | -4.00K | -16.00K | -8.00K | -12.00K | -54.00K |
Issuance of Common Stock | 23.00K | 0.00 | 116.00K | -- | 45.00K |
Repurchase of Common Stock | -14.00K | -111.00K | -76.00K | -153.00K | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | 0.00 |
Cash from Financing | 5.00K | -127.00K | 32.00K | -165.00K | -246.00K |
Foreign Exchange rate Adjustments | -87.00K | -1.96M | 2.58M | 223.00K | 1.10M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -28.83M | -9.71M | 34.98M | -7.95M | -7.23M |